Home > Financial Ratios > LINCOLN PHARMACEUTICALS

LINCOLN PHARMACEUTICALS
EV/EBIT

    Back to All Ratios
LINCOLN PHARMACEUTICALS is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for LINCOLN PHARMACEUTICALS
Please provide your vote to see the results

LINCOLN PHARMACEUTICALS Last 5 Year EV/EBIT History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
   EV/EBIT(x) 9.459.749.386.306.23

What is the latest EV/EBIT ratio of LINCOLN PHARMACEUTICALS ?

The latest EV/EBIT ratio of LINCOLN PHARMACEUTICALS is 9.45 based on Mar2026 Consolidated results.
Year EV/EBIT
Mar20269.45
Mar20259.74
Mar20249.38
Mar20236.30
Mar20226.23

How is EV/EBIT of LINCOLN PHARMACEUTICALS Trending?

Years EV/EBIT % Change
Mar2026 9.45
-2.98
Mar2025 9.74
3.84
Mar2024 9.38
48.89
Mar2023 6.3
1.12
Mar2022 6.23 -

Other Financial Ratios of LINCOLN PHARMACEUTICALS


Compare EV/EBIT ratio of peers of LINCOLN PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
LINCOLN PHARMACEUTICALS ₹1,137.1 Cr -2.4% -7.9% 8.3% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹427,562.0 Cr -3.2% -7.8% 14.1% Stock Analytics
DIVIS LABORATORIES ₹244,572.0 Cr -3.3% -0.2% 63.3% Stock Analytics
TORRENT PHARMACEUTICALS ₹180,871.0 Cr -2.4% -5% 33.6% Stock Analytics
CIPLA ₹107,770.0 Cr -4% -5.6% -10.2% Stock Analytics
DR REDDYS LABORATORIES ₹100,829.0 Cr -1.2% 4.1% -4.2% Stock Analytics


LINCOLN PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
LINCOLN PHARMACEUTICALS

-2.4%

-7.9%

8.3%

SENSEX

-2.1%

-5.9%

-10.8%


You may also like the below Video Courses